Veterinary Animal-Derived Therapeutic Peptide Development

Therapeutic animal-derived peptide development is a multifaceted field that harnesses the unique bioactive compounds in various animal sources to create innovative peptides for veterinary use. BioVenic provides comprehensive and one-stop services for therapeutic animal-derived peptide development. Our expertise spans venom-derived peptides from sources like snakes and scorpions, marine-derived peptides from sea organisms, and non-marine-derived peptides from terrestrial animals. Each type offers unique therapeutic potentials, from pain management to anti-infective treatments. BioVenic specializes in the extraction, purification, characterization, and large-scale production of these peptides.

Animal-Derived Therapeutic Peptide Development Overview

Veterinary animal-derived peptides are known for their potent biological activities and specificity. In veterinary medicine, these peptides are developed to provide targeted therapeutic interventions, offering new solutions for managing pain, infections, and chronic diseases in animals. The development process involves the extraction, purification, and characterization of these peptides, followed by large-scale production to ensure they meet the necessary standards for veterinary use. This approach not only improves animal health and welfare but also supports advancements in the veterinary pharmaceutical industry.

Animal-Derived Therapeutic Peptide Development One-Stop Service

BioVenic offers a one-stop and professional service for animal-derived therapeutic peptide development. This service covers all stages of the development process, from initial peptide extraction to final product formulation, ensuring quality, efficiency, and safety.

Fig.1 Veterinary animal-derived therapeutic peptide development one-stop service at BioVenic. (BioVenic Original)

Animal-Derived Veterinary Therapeutic Peptide Development Platforms

• Vemon-Derived Therapeutic Peptide Development

BioVenic excels in developing veterinary therapeutic venom-derived peptides, leveraging the unique bioactive compounds found in venomous animals like snakes, spiders, and scorpions. These peptides are characterized by their complex structures, including large molecular weights and multiple disulfide bonds, contributing to their high specificity and potency. Unlike traditional small-molecule drugs, venom-derived peptides offer a lower off-target effect and metabolize into non-toxic amino acids, making them safer alternatives. With extensive experience in peptide extraction, purification, and modification, BioVenic transforms these natural toxins into powerful therapeutic agents for conditions like chronic pain, offering innovative solutions in veterinary medicine preclinical research for clients.

Fig.2 Families of venom-derived peptides from South American organisms. ^{1, 2}

• Marine-Derived Therapeutic Peptide Development

Marine-derived therapeutic peptides hold significant promise in veterinary medicine due to their unique structures, low toxicity, and potent biological activities. These peptides, particularly cyclic ones, offer advantages such as enhanced binding affinity, selectivity, and metabolic stability, making them ideal for treating various veterinary conditions, including antimicrobial resistance and parasitic infections. By exploring both natural and synthetic derivatives, these peptides provide innovative, safe, and effective solutions for advancing animal health in the veterinary field. BioVenic provides innovative, safe, and targeted solutions to address critical veterinary challenges such as antimicrobial resistance and parasitic infections, ultimately advancing animal health through cutting-edge biotechnology.

Fig.3 The peptides extracted from different marine species.^3,4

Service Workflow

The workflow for developing animal-derived veterinary peptides involves several key stages: First, ethical sourcing and raw material collection are conducted. These materials then undergo preprocessing and peptide extraction. The extracted peptides are purified, and their activity is confirmed. Following this, rigorous safety and efficacy evaluations are performed. Finally, the peptides are scaled up for production and undergo strict quality control to ensure they meet the necessary standards for veterinary use.

Fig.4 The animal-derived veterinary therapeutic peptide development service workflow. (BioVenic Original)

Why Choose Us?

BioVenic specializes in offering a fully integrated solution for discovering and producing animal-derived veterinary therapeutic peptides. With over a decade of experience in managing R&D projects, we are well-equipped to employ a variety of methods and procedures to produce veterinary peptides from diverse animal species tailored to your needs. Get in touch with us today for detailed information and tailored support.

BioVenic offers one-stop and comprehensive services for animal-derived veterinary therapeutic peptide development. For more services, please click the link below to learn more details.

• Veterinary Therapeutic Protein and Peptide Identification and Characterization
• Veterinary Therapeutic Peptide Purification
• Veterinary Therapeutic Protein and Peptide Formulation, Manufacturing and Quality Control

References

1. Ageitos, Lucía, Marcelo DT Torres, and Cesar de la Fuente-Nunez. "Biologically active peptides from venoms: applications in antibiotic resistance, cancer, and beyond." International Journal of Molecular Sciences 23.23 (2022): 15437.
2. Image retrieved from Figure 1 "Families of venom-derived peptides from South American organisms". Ageitos, Lucía, et al., 2022, used under CC BY 4.0, the title was changed to "Families of venom-derived peptides from South American organisms".
3. Ribeiro, Ricardo,et al."Therapeutic Potential of Marine-Derived Cyclic Peptides as Antiparasitic Agents." Marine Drugs 21.12 (2023): 609.
4. Image retrieved from "Graphical Abstract". Ribeiro, Ricardo, et al., 2023, used under CC BY 4.0, the title was changed to "The peptides extracted from different marine species".